Locations:

Cancer

April 2, 2019/Cancer/Patient Support

In Search of a Standardized Tool for Assessing Psychosocial Status of HCT Candidates

Can PACT pinpoint vulnerable patients?

April 1, 2019/Cancer

A PCP’s Guide to Screening for Monoclonal Gammopathy of Undetermined Significance

When and how to investigate further

March 29, 2019/Cancer/Blood Cancers

National Data Show Misdiagnoses Common for Patients with Myelodysplastic Syndromes

Preliminary results from a national registry

March 25, 2019/Cancer/Blood Cancers

Azacitidine Shows Potential in Treating AML and MDS Relapse Following Stem Cell Transplantation

May offer much needed treatment option for patients who relapse early

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

March 22, 2019/Cancer/News & Insight

Time-to-Treat, Two Years Later

Our Cancer Center Chair reflects on progress and potential

March 22, 2019/Basic & Translational Science/Research

Pathway that Mediates Cytotoxicity of AZA Discovered

What we know so far about the OAS-RNase L innate immune pathway

March 21, 2019/Cancer/News & Insight

Understanding Rheumatologic Immune-Related Adverse Events in Genitourinary Cancers

Cases of myalgia and arthralgia after CPI

18-HRT-311-Valley-Health-CQD-Hero-650×428

March 20, 2019/Cancer

Echocardiographic Screening Likely Unnecessary in Some Long-Term Pediatric Stem Cell Transplant Survivors

New study stratifies cardiac risk in radiation- and anthracycline-exposed patients

March 19, 2019/Cancer/Blood Cancers

Maintenance Rituximab Extends Remission in Pretreated Patients with Follicular Lymphoma

Patients in partial remission improve further

March 18, 2019/Cancer

Identifying Lung Cancer Risk Factors in Lung Transplant Recipients

Registry linkage study reports on incidence, risk factors and survival

BackPage 70 of 113Next